Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +41 vs. Q4 2023
- Shares held
- 39.3M
- +7.14M (+22.2%) vs. Q4 2023
- Total value
- $1.43B
- +$777.5M (+119.3%) vs. Q4 2023
- New holders
- 47
- 59 more added
- Sold out
- 6
- 33 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Standard Life Aberdeen plc | 72,032 | $2.62M | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 73,900 | $2.69M | 0.01% | +7,600+11.5% | Added |
| Lord, Abbett & Co. LLC | 82,226 | $2.99M | 0.01% | +82,226 | New |
| Bank of New York Mellon Corp | 96,409 | $3.50M | 0.00% | +14,212+17.3% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 97,047 | $3.53M | 0.02% | +6,964+7.7% | Added |
| Laurion Capital Management LP | 100,000 | $3.63M | 0.10% | +100,000 | New |
| EAM Investors, LLC | 100,658 | $3.66M | 0.58% | +100,658 | New |
| Wellington Management Group LLP | 111,422 | $4.05M | 0.00% | +111,422 | New |
| Baird Financial Group, Inc. | 128,272 | $4.66M | 0.01% | +128,272 | New |
| Two Sigma Investments, LP | 147,826 | $5.37M | 0.01% | +75,886+105.5% | Added |
| CIBC World Markets Inc. | 150,000 | $5.45M | 0.01% | +150,000 | New |
| CIBC World Markets Corp | 150,000 | $5.45M | 0.04% | +150,000 | New |
| Macquarie Group Ltd | 150,000 | $5.45M | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 150,321 | $5.46M | 0.54% | −224,955−59.9% | Reduced |
| Nuveen Asset Management, LLC | 156,787 | $5.70M | 0.00% | −79,655−33.7% | Reduced |
| Norges Bank | 160,100 | $5.82M | 0.00% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 161,163 | $5.86M | 0.06% | +161,163 | New |
| J. Goldman & Co LP | 163,347 | $5.94M | 0.27% | +91,003+125.8% | Added |
| Sands Capital Ventures, LLC | 170,000 | $6.18M | 1.49% | −90,000−34.6% | Reduced |
| Boothbay Fund Management, LLC | 175,512 | $6.38M | 0.19% | +63,740+57.0% | Added |
| Allspring Global Investments Holdings, LLC | 192,303 | $6.99M | 0.01% | +4,889+2.6% | Added |
| D. E. Shaw & Co., Inc. | 196,512 | $7.14M | 0.01% | +155,985+384.9% | Added |
| Goldman Sachs Group Inc | 203,730 | $7.41M | 0.00% | −33,709−14.2% | Reduced |
| ExodusPoint Capital Management, LP | 215,958 | $7.85M | 0.10% | −16,942−7.3% | Reduced |
| Citadel Advisors LLC | 219,278 | $7.97M | 0.01% | +176,241+409.5% | Added |
| Charles Schwab Investment Management Inc | 221,997 | $8.07M | 0.00% | +3,335+1.5% | Added |
| StemPoint Capital LP | 222,253 | $8.08M | 2.16% | +191,263+617.2% | Added |
| Invesco Ltd. | 223,569 | $8.13M | 0.00% | +125,696+128.4% | Added |
| Bank of America Corp | 229,492 | $8.34M | 0.00% | −9,331−3.9% | Reduced |
| Northern Trust Corp | 247,177 | $8.98M | 0.00% | −1,573−0.6% | Reduced |
| Jefferies Financial Group Inc. | 270,758 | $9.84M | 0.20% | −110,000−28.9% | Reduced |
| Walleye Capital LLC | 272,498 | $9.91M | 0.11% | +272,498 | New |
| Ghost Tree Capital, LLC | 300,000 | $10.9M | 3.51% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 347,683 | $12.6M | 0.00% | +347,683 | New |
| Dimensional Fund Advisors LP | 424,830 | $15.4M | 0.00% | −5,297−1.2% | Reduced |
| Polygon Management Ltd. | 450,000 | $16.4M | 4.50% | −350,000−43.8% | Reduced |
| Vivo Capital, LLC | 565,550 | $20.6M | 1.62% | −1,218,456−68.3% | Reduced |
| Integral Health Asset Management, LLC | 590,000 | $21.4M | 2.11% | +490,000+490.0% | Added |
| Boone Capital Management LLC | 609,104 | $22.1M | 4.48% | +609,104 | New |
| Artisan Partners Limited Partnership | 627,430 | $22.8M | 0.03% | +237,419+60.9% | Added |
| Geode Capital Management, LLC | 629,692 | $22.9M | 0.00% | +19,956+3.3% | Added |
| Ikarian Capital, LLC | 710,277 | $25.8M | 7.02% | +191,758+37.0% | Added |
| State Street Corp | 717,090 | $26.1M | 0.00% | +42,259+6.3% | Added |
| Ensign Peak Advisors, Inc | 727,891 | $26.5M | 0.05% | +290,000+66.2% | Added |
| TCG Crossover Management, LLC | 793,829 | $28.9M | 2.28% | −349,028−30.5% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 898,000 | $32.6M | 0.11% | +824,000+1,113.5% | Added |
| Perceptive Advisors LLC | 1,296,416 | $47.1M | 0.83% | 00.0% | Unchanged |
| Jennison Associates LLC | 1,330,938 | $48.4M | 0.03% | +1,330,938 | New |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $65.0M | 2.74% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,826,632 | $66.4M | 0.00% | +231,131+14.5% | Added |
| Cowen and Company, LLC | 2,122,530 | $77.2M | 3.01% | +211,131+11.0% | Added |
| Cormorant Asset Management, LP | 2,139,102 | $77.8M | 3.43% | −82,320−3.7% | Reduced |
| Tang Capital Management LLC | 2,254,797 | $82.0M | 8.53% | +50,000+2.3% | Added |
| Morgan Stanley | 2,398,918 | $87.2M | 0.01% | +441,230+22.5% | Added |
| BlackRock Inc. | 2,652,680 | $96.4M | 0.00% | +136,541+5.4% | Added |
| Paradigm Biocapital Advisors LP | 2,863,406 | $104.1M | 3.66% | +1,838,406+179.4% | Added |
| RTW Investments, LP | 3,272,341 | $118.9M | 1.76% | +120,000+3.8% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −19,575−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −14,056−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −11,226−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −11,075−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −57−100.0% | Sold out |